HeliosX, the London-based online pharmacy, has made significant strides in the weight-loss drug market, recently boasting a remarkable reduction of 8.5 million kilograms in patient weight, equating to approximately 3.5
All posts tagged in Healthcare
21Articles
Recent developments regarding Iran’s threats to close the Strait of Hormuz have sparked significant concerns among pharmacists and healthcare professionals in the UK. As a crucial maritime route for oil
The UK Biobank has reached a significant milestone by enabling access to GP medical records, a development poised to revolutionise the understanding of chronic diseases and ageing. This initiative allows
The life sciences sector in the United Kingdom is encountering significant challenges as new reforms regarding the National Health Service (NHS) drug evaluation process come into effect. Johan Kahlstrom, the
Weight-loss drugs have experienced a remarkable rise in the UK since their approval in 2023. As many as 1.5 million Britons are now reported to be using GLP-1 medications for
Britain’s largest private hospital operator, Spire Healthcare Group, is reportedly in discussions with major private equity firms, including Bridgepoint and Triton Partners, regarding a potential acquisition that could value the
GlaxoSmithKline (GSK) has announced its acquisition of a US biopharmaceutical company, RAPT Therapeutics, for a sum of 2.2 billion dollars. This strategic move marks GSK’s first bolt-on acquisition under the
British expatriates residing in France may soon face significant changes to their access to free healthcare as French lawmakers advance measures to close a longstanding loophole. Presently, expats not engaged
Weight loss medications, specifically GLP1 agonists like Ozempic Wegovy and Mounjaro, are redefining the landscape of healthcare in Britain, with new research signposting not only longer lives for millions but
Assura the NHS landlord at the centre of a lengthy bidding war has reported strong annual results that strengthen shareholder resolve to resist a buyout by private equity. The FTSE
WeightWatchers is embarking on a transformative journey following a significant debt restructuring, positioning itself to compete in the evolving landscape of weight management solutions. The company, which recently emerged from
Private healthcare giant Bupa has been ordered to pay £17 million in compensation to Australian members following revelations that the company deliberately blocked legitimate health insurance claims. The Australian Competition
The UK’s leading pharmacy and retail chain Boots has delivered another robust quarter of growth, marking its 17th consecutive period of market share gains amid an impending £10 billion private
The National Health Service faces a mounting crisis as overseas-trained medical professionals increasingly opt for more lucrative positions in the United States, Australia, and Canada, according to new research from
The NHS is embarking on a significant initiative aimed at removing up to 300,000 patients from its waiting lists in an effort to streamline operations and enhance patient care. This
Almost £8 billion has been erased from the value of the world’s largest pharmaceutical companies following the unexpected ousting of America’s leading vaccine authority by Robert F Kennedy Jr. Shares
- 1
- 2
